SE9600647D0 - Ny användning - Google Patents
Ny användningInfo
- Publication number
- SE9600647D0 SE9600647D0 SE9600647A SE9600647A SE9600647D0 SE 9600647 D0 SE9600647 D0 SE 9600647D0 SE 9600647 A SE9600647 A SE 9600647A SE 9600647 A SE9600647 A SE 9600647A SE 9600647 D0 SE9600647 D0 SE 9600647D0
- Authority
- SE
- Sweden
- Prior art keywords
- mucous membranes
- new use
- protein
- tropism
- immunogen
- Prior art date
Links
- 230000002163 immunogen Effects 0.000 abstract 2
- 210000004400 mucous membrane Anatomy 0.000 abstract 2
- 102000004169 proteins and genes Human genes 0.000 abstract 2
- 108090000623 proteins and genes Proteins 0.000 abstract 2
- 150000001720 carbohydrates Chemical class 0.000 abstract 1
- 229930182470 glycoside Natural products 0.000 abstract 1
- 150000002338 glycosides Chemical class 0.000 abstract 1
- 230000028993 immune response Effects 0.000 abstract 1
- 150000002632 lipids Chemical class 0.000 abstract 1
- 210000003563 lymphoid tissue Anatomy 0.000 abstract 1
- 230000008685 targeting Effects 0.000 abstract 1
- 230000010415 tropism Effects 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/39—Medicinal preparations containing antigens or antibodies characterised by the immunostimulating additives, e.g. chemical adjuvants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
- A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/54—Medicinal preparations containing antigens or antibodies characterised by the route of administration
- A61K2039/541—Mucosal route
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
- A61K2039/55511—Organic adjuvants
- A61K2039/55577—Saponins; Quil A; QS21; ISCOMS
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Epidemiology (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Microbiology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Mycology (AREA)
- Immunology (AREA)
- Virology (AREA)
- Communicable Diseases (AREA)
- Organic Chemistry (AREA)
- Oncology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Emulsifying, Dispersing, Foam-Producing Or Wetting Agents (AREA)
- Cosmetics (AREA)
- Medicinal Preparation (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Priority Applications (12)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| SE9600647A SE9600647D0 (sv) | 1996-02-21 | 1996-02-21 | Ny användning |
| DE69726712T DE69726712T2 (de) | 1996-02-21 | 1997-02-20 | Iscom oder iscom-matrix, welche einen gegen die schleimhaut gerichteten wirkstoff und ein antigen enthält |
| JP9530070A JP2000504746A (ja) | 1996-02-21 | 1997-02-20 | 粘液ターゲティング物質、および抗原を随時含むイスコムまたはイスコム―マトリックス |
| DK97905541T DK0889736T3 (da) | 1996-02-21 | 1997-02-20 | Iscom eller iscom-matrix, der omfatter et stof, der retter sig mod mucus, og et antigen |
| AT97905541T ATE255905T1 (de) | 1996-02-21 | 1997-02-20 | Iscom oder iscom-matrix, welche einen gegen die schleimhaut gerichteten wirkstoff und ein antigen enthält |
| CA002247522A CA2247522C (fr) | 1996-02-21 | 1997-02-20 | Compose immunostimulateur ou matrice de composes immunostimulateurs renfermant une substance ciblant le mucus et, facultativement, un antigene |
| AU22385/97A AU719084B2 (en) | 1996-02-21 | 1997-02-20 | Iscom or iscom-matrix comprising a mucus targetting substance and optionally, an antigen |
| NZ331403A NZ331403A (en) | 1996-02-21 | 1997-02-20 | Iscom or iscom-matrix comprising a mucus targetting substance and optionally, an antigen |
| EP97905541A EP0889736B1 (fr) | 1996-02-21 | 1997-02-20 | Compose immunostimulateur ou matrice de composes immunostimulateurs renfermant une substance ciblant le mucus et un antigene |
| PCT/SE1997/000289 WO1997030728A1 (fr) | 1996-02-21 | 1997-02-20 | Compose immunostimulateur ou matrice de composes immunostimulateurs renfermant une substance ciblant le mucus et, facultativement, un antigene |
| ES97905541T ES2210495T3 (es) | 1996-02-21 | 1997-02-20 | Iscom o matriz de iscom que comprende una sustancia dirigida especificamente a las mucosas y un antigeno. |
| US09/137,236 US6607732B2 (en) | 1996-02-21 | 1998-08-20 | ISCOM or ISCOM-matrix comprising a mucous targetting substance and an antigen |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| SE9600647A SE9600647D0 (sv) | 1996-02-21 | 1996-02-21 | Ny användning |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| SE9600647D0 true SE9600647D0 (sv) | 1996-02-21 |
Family
ID=20401481
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| SE9600647A SE9600647D0 (sv) | 1996-02-21 | 1996-02-21 | Ny användning |
Country Status (12)
| Country | Link |
|---|---|
| US (1) | US6607732B2 (fr) |
| EP (1) | EP0889736B1 (fr) |
| JP (1) | JP2000504746A (fr) |
| AT (1) | ATE255905T1 (fr) |
| AU (1) | AU719084B2 (fr) |
| CA (1) | CA2247522C (fr) |
| DE (1) | DE69726712T2 (fr) |
| DK (1) | DK0889736T3 (fr) |
| ES (1) | ES2210495T3 (fr) |
| NZ (1) | NZ331403A (fr) |
| SE (1) | SE9600647D0 (fr) |
| WO (1) | WO1997030728A1 (fr) |
Families Citing this family (23)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6207646B1 (en) | 1994-07-15 | 2001-03-27 | University Of Iowa Research Foundation | Immunostimulatory nucleic acid molecules |
| US6406705B1 (en) | 1997-03-10 | 2002-06-18 | University Of Iowa Research Foundation | Use of nucleic acids containing unmethylated CpG dinucleotide as an adjuvant |
| ATE335510T1 (de) | 1998-05-22 | 2006-09-15 | Ottawa Health Research Inst | Methoden und produkte zur induzierung mukosaler immunität |
| US7041296B1 (en) * | 1999-11-12 | 2006-05-09 | The United States Of America As Represented By The Department Of Health And Human Services | Methods of treating inflammatory bowel disease using cholera toxin B subunit |
| US7713942B2 (en) * | 2001-04-04 | 2010-05-11 | Nordic Vaccine Technology A/S | Cage-like microparticle complexes comprising sterols and saponins for delivery of polynucleotides |
| SE0202110D0 (sv) | 2002-07-05 | 2002-07-05 | Isconova Ab | Iscom preparation and use thereof |
| SE0301998D0 (sv) * | 2003-07-07 | 2003-07-07 | Isconova Ab | Quil A fraction with low toxicity and use thereof |
| EP1838341B1 (fr) | 2005-01-20 | 2013-08-14 | Isconova AB | Composition vaccinale comprenant une proteine ou un peptide de liaison a la fibronectine |
| CA2698392C (fr) | 2007-09-04 | 2019-12-03 | Baoming Jiang | Inactivation thermique de rotavirus |
| GB0803076D0 (en) * | 2008-02-20 | 2008-03-26 | Univ Ghent | Mucosal Membrane Receptor and uses thereof |
| ES2325243B1 (es) * | 2008-02-27 | 2011-05-04 | Universidad De Granada | Antigeno recombinante. |
| PL3067064T3 (pl) | 2008-12-09 | 2020-11-02 | Novavax, Inc. | Zmodyfikowane białka f rsv i sposoby ich wykorzystania |
| NZ606087A (en) | 2010-07-23 | 2014-06-27 | Isconova Ab | Influenza vaccine |
| KR20200040899A (ko) | 2011-05-13 | 2020-04-20 | 조에티스 서비시즈 엘엘씨 | 헨드라 및 니파 바이러스 ｇ 당단백질 면역원성 조성물 |
| TR201808733T4 (tr) | 2011-10-03 | 2018-07-23 | Mx Adjuvac Ab | Kanser tedavisini ve gıda ile ilgili bileşikleri içeren tıp alanlarında amfipatik veya hidrofobik moleküller için taşıyıcı olarak nano-parçacıklar, preparasyon için proses ve bunların kullanımı. |
| WO2014124228A1 (fr) | 2013-02-07 | 2014-08-14 | Children's Medical Center Corporation | Antigènes de protéine qui confèrent une protection contre une colonisation et/ou une maladie pneumococcique |
| AR095962A1 (es) | 2013-04-01 | 2015-11-25 | Moreinx Ab | Nanopartículas, compuestas de esterol y saponina de quillaja saponaria molina, proceso para preparación y uso de las mismas como portadores para moléculas anfipáticas o hidrófobas en el campo de la medicina incluyendo tratamiento de cáncer y compuestos relacionados con alimentos |
| KR20160077214A (ko) | 2013-12-16 | 2016-07-01 | 조에티스 서비시즈 엘엘씨 | 헨드라 및 니파 바이러스 ｇ 당단백질 면역원성 조성물 |
| US10426829B2 (en) | 2015-09-03 | 2019-10-01 | Novavax, Inc. | Vaccine compositions having improved stability and immunogenicity |
| ES3028362T3 (en) | 2017-07-24 | 2025-06-19 | Novavax Inc | Methods and compositions for treating respiratory disease |
| CA3092984A1 (fr) | 2018-03-19 | 2019-09-26 | Novavax, Inc. | Vaccins multivalents contre la grippe a base de nanoparticules |
| US10953089B1 (en) | 2020-01-27 | 2021-03-23 | Novavax, Inc. | Coronavirus vaccine formulations |
| GB202209588D0 (en) | 2022-06-29 | 2022-08-10 | Plant Bioscience Ltd | Methods and compositions |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6290962B1 (en) * | 1992-11-03 | 2001-09-18 | Oravax, Inc. | Urease-based vaccine and treatment for helicobacter infection |
-
1996
- 1996-02-21 SE SE9600647A patent/SE9600647D0/xx unknown
-
1997
- 1997-02-20 DE DE69726712T patent/DE69726712T2/de not_active Expired - Lifetime
- 1997-02-20 AT AT97905541T patent/ATE255905T1/de not_active IP Right Cessation
- 1997-02-20 WO PCT/SE1997/000289 patent/WO1997030728A1/fr not_active Ceased
- 1997-02-20 EP EP97905541A patent/EP0889736B1/fr not_active Expired - Lifetime
- 1997-02-20 AU AU22385/97A patent/AU719084B2/en not_active Expired
- 1997-02-20 NZ NZ331403A patent/NZ331403A/en not_active IP Right Cessation
- 1997-02-20 DK DK97905541T patent/DK0889736T3/da active
- 1997-02-20 CA CA002247522A patent/CA2247522C/fr not_active Expired - Lifetime
- 1997-02-20 JP JP9530070A patent/JP2000504746A/ja active Pending
- 1997-02-20 ES ES97905541T patent/ES2210495T3/es not_active Expired - Lifetime
-
1998
- 1998-08-20 US US09/137,236 patent/US6607732B2/en not_active Expired - Lifetime
Also Published As
| Publication number | Publication date |
|---|---|
| AU2238597A (en) | 1997-09-10 |
| DE69726712T2 (de) | 2004-10-07 |
| ATE255905T1 (de) | 2003-12-15 |
| NZ331403A (en) | 2000-02-28 |
| CA2247522C (fr) | 2009-12-29 |
| DK0889736T3 (da) | 2004-04-19 |
| AU719084B2 (en) | 2000-05-04 |
| JP2000504746A (ja) | 2000-04-18 |
| EP0889736B1 (fr) | 2003-12-10 |
| EP0889736A1 (fr) | 1999-01-13 |
| WO1997030728A1 (fr) | 1997-08-28 |
| ES2210495T3 (es) | 2004-07-01 |
| CA2247522A1 (fr) | 1997-08-28 |
| US6607732B2 (en) | 2003-08-19 |
| US20020131982A1 (en) | 2002-09-19 |
| DE69726712D1 (de) | 2004-01-22 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| SE9600647D0 (sv) | Ny användning | |
| DE69019164D1 (de) | Verbessertes meningokokkale polysaccharidkonjugatvakzin. | |
| IS4518A (is) | Nýtt lyfjaform fyrir bóluefni | |
| GB2303855B (en) | Helicobacter pylori antigenic protein preparation and immunoassays | |
| BR9814483A (pt) | "vacina" | |
| NO991524L (no) | Vaksiner | |
| CY1107457T1 (el) | Εμβoλιο κατa του hpv | |
| NO982497D0 (no) | Vaksine-sammensetninger for inntak gjennom nesen | |
| GB9713156D0 (en) | Vaccines | |
| MX9203808A (es) | Formulaciones de alto contenido de medicamento: lipido, de agentes liposomicos-antineoplasticos. | |
| DZ2462A1 (fr) | Vaccin antigrippal. | |
| AU8113591A (en) | Coconjugate vaccines comprising immunogenic protein, hiv related peptides, and anionic moieties | |
| AU1440099A (en) | Mixed lipopeptide micelles for inducing an immune response and their therapeut icuses | |
| BR9610679A (pt) | Antígenos de leishmania para uso na terapia e disgnose da leishmaniose | |
| IT1234817B (it) | Tappeto per idromassaggi. | |
| AUPM399594A0 (en) | Antigenic preparation for treatment or prevention of helicobacter infection | |
| AU9635998A (en) | Solid dispersing vaccine composition for oral delivery | |
| NO972219D0 (no) | Immunogenpreparater | |
| FR2669346B1 (fr) | Vaccin a poxvirus recombinant contre le virus de la rougeole. | |
| WO2001034185A3 (fr) | Induction d'une immunite au niveau des muqueuses par vaccination percutanee | |
| FR2715304B1 (fr) | Vaccin anti-allergique. | |
| EP0584212A4 (fr) | Vaccins comprenant un polysaccharide encapsule dans un liposome. | |
| WO2001037862A3 (fr) | Vaccin a base de lactobacilles pour le traitement des inflammations de la prostate et de l'hyperplasie benigne de la prostate | |
| AU1825895A (en) | Retroviral vaccines, vaccination and immune-therapy for retroviral infections | |
| SE9600646D0 (sv) | Vaccin |